Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EBS Emergent Biosolutions

盘后交易 05-06 19:28:56 EDT

3.98

+0.09

+2.31%

盘后4.00

+0.02+0.51%

19:14 EDT

最高4.51	最低3.84	成交量938.77万
今开3.88	昨收3.89	日振幅17.22%
总市值2.09亿	流通市值2.06亿	总股本5,240万
成交额3,963万	换手率18.16%	流通股本5,170万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent Biosolutions","latestPrice":3.98,"timestamp":1715025600000,"preClose":3.89,"halted":0,"volume":9387674,"hourTrading":{"tag":"盘后","latestPrice":4.0001,"preClose":3.98,"latestTime":"19:14 EDT","volume":17854,"amount":71129.407592,"timestamp":1715037244622},"delay":0,"floatShares":51695572,"shares":52401850,"eps":-10.934235,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.09,"latestTime":"05-06 19:28:56 EDT","open":3.88,"high":4.51,"low":3.84,"amount":39630460.073308006,"amplitude":0.172237,"askPrice":4.05,"askSize":500,"bidPrice":3.92,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-10.934235,"exchange":"NYSE","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715040000000},"adr":0,"listingDate":1254456000000,"adjPreClose":3.89,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.8624,"preClose":3.89,"latestTime":"09:29 EDT","volume":94540,"amount":367724.750432,"timestamp":1715002198568},"postHourTrading":{"tag":"盘后","latestPrice":4.0001,"preClose":3.98,"latestTime":"19:14 EDT","volume":17854,"amount":71129.407592,"timestamp":1715037244622},"volumeRatio":0.26723},"requestUrl":"/m/hq/s/EBS/wiki","defaultTab":"wiki","newsList":[{"id":"2433576479","title":"Emergent Biosolutions, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433576479","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433576479?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:31","pubTimestamp":1715002302,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时31分，Emergent Biosolutions, Inc.股票出现异动，股价急速拉升5.14%。截至发稿，该股报4.09美元/股，成交量34.5396万股，换手率0.66%，振幅5.91%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.22%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Optinose, Inc.、Intercure Ltd.涨幅较大，Sunshine Biopharma Inc.、Akanda Corp.、苏轩堂较为活跃，换手率分别为690.43%、3.29%、1.60%，振幅较大的相关个股有Emergent Biosolutions, Inc.、Akanda Corp.、Sunshine Biopharma Inc.，振幅分别为5.91%、3.65%、3.24%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062131437a5847d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062131437a5847d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432903842","title":"Emergent Biosolutions, Inc.盘中异动 股价大涨6.14%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432903842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432903842?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743152,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Emergent Biosolutions, Inc.股票出现异动，股价急速拉升6.14%。截至发稿，该股报3.50美元/股，成交量119.865万股，换手率2.29%，振幅5.15%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体跌幅为0.23%。其相关个股中，安进、Durect Corporation、Sunshine Biopharma Inc.涨幅较大，Sunshine Biopharma Inc.、Akanda Corp.、苏轩堂较为活跃，换手率分别为109.49%、15.42%、3.22%，振幅较大的相关个股有Durect Corporation、Amneal Pharmaceuticals, Inc.、Fsd Pharma Inc.，振幅分别为8.08%、7.47%、7.42%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321323387ce8e39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321323387ce8e39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432601106","title":"Emergent Biosolutions, Inc.盘中异动 早盘快速拉升52.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601106","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432601106?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:30","pubTimestamp":1714656605,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时30分，Emergent Biosolutions, Inc.股票出现异动，股价快速拉升52.85%。截至发稿，该股报2.95美元/股，成交量923.725万股，换手率17.63%，振幅0.00%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Emergent Biosolutions, Inc.、硕腾、Cbdmd, Inc.涨幅较大，Akanda Corp.、Sunshine Biopharma Inc.、Emergent Biosolutions, Inc.较为活跃，换手率分别为44.51%、20.91%、17.63%，振幅较大的相关个股有硕腾、Cbdmd, Inc.、Viatris Inc.，振幅分别为0.00%、0.00%、0.00%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022130057925b19e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022130057925b19e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432676050","title":"BUZZ-新任首席执行官上任后，Emergent 生物公司因裁员而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2432676050","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432676050?lang=zh_cn&edition=full","pubTime":"2024-05-02 19:18","pubTimestamp":1714648683,"startTime":"0","endTime":"0","summary":"    5月2日 - ** 制药商Emergent BioSolutions   的股价在盘前大涨70%，至3.29美元，是开盘前美国各交易所中涨幅最大的公司。** Papa 被任命为首席执行官时，公司股价飙升了近 80%，但此后收窄了一些涨幅；EBS 股价今年以来下跌了近 20%。** 自 2021 年以来，EBS 的股价一直处于年度亏损状态，原因是该公司报告了季度亏损，并在合同制造业务方面陷入困境。** 开盘前 EBS 股票成交量超过 430 万股，成为美国交易所成交第二活跃的股票","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432663476","title":"Emergent BioSolutions 公司报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432663476","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432663476?lang=zh_cn&edition=full","pubTime":"2024-05-02 07:19","pubTimestamp":1714605543,"startTime":"0","endTime":"0","summary":"   * Emergent BioSolutions Inc   公布的截至3月底的季度调整后每股收益为59美分，高于去年同期的每股收益3.17美元。两位分析师对该季度的平均预期是每股亏损 86 美分。华尔街预期为每股-89美分至-83美分。* 营收同比增长 82%，达到 3.004 亿美元；分析师预期为 2.2025 亿美元。* Emergent BioSolutions 公司公布的本季度每股收益为 17 美分。* 公司报告的季度净收入为 900 万美元。* 本季度，Emergent BioSolutions Inc 的股价下跌了 25.7%，今年迄今为止下跌了 21.7%。华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 5.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432630108","title":"更新版 1-新兴生物解决方案公司将裁员约 300 人","url":"https://stock-news.laohu8.com/highlight/detail?id=2432630108","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432630108?lang=zh_cn&edition=full","pubTime":"2024-05-02 04:34","pubTimestamp":1714595669,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (补充重组细节)    路透5月1日 - Emergent BioSolutions   周三表示，作为重组计划的一部分，公司将在所有领域 裁员约300人，并关闭几家生产厂 。 由于需求低迷，Emergent一直在寻求削减成本，并放弃合同生产业务。      去年，该公司裁减了 400 名员工，并缩减了部分工厂的运营规模，专注于过量用药逆转鼻喷雾剂 Narcan 等核心产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432570816","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大涨5.16%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570816","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432570816?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:38","pubTimestamp":1714570681,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时38分，Emergent Biosolutions, Inc.股票出现波动，股价快速上涨5.16%。截至发稿，该股报1.98美元/股，成交量13.0861万股，换手率0.25%，振幅5.32%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.05%。其相关个股中，Akanda Corp.、Im Cannabis Corp.、Sunshine Biopharma Inc C/Wts 涨幅较大，Akanda Corp.、Im Cannabis Corp.、Sunshine Biopharma Inc.较为活跃，换手率分别为765.89%、105.44%、30.94%，振幅较大的相关个股有Akanda Corp.、Bright Green Corporation、Im Cannabis Corp.，振幅分别为24.09%、17.50%、15.12%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213802861ea864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213802861ea864&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431878434","title":"Emergent BioSolutions Inc   预计每股亏损83美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431878434","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431878434?lang=zh_cn&edition=full","pubTime":"2024-04-30 06:37","pubTimestamp":1714430232,"startTime":"0","endTime":"0","summary":"   * Emergent生物解决方案公司   5月1日发布的截至2024年3月31日的财报显示，该公司的季度收入预计将有所增长。)   * LSEG 分析师对 Emergent BioSolutions 公司的平均预期是每股亏损 83 美分。* 华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 5.00 美元，高于其最新收盘价 1.89 美元。4月29日 - 本摘要于北京时间 4 月 29 日 22:37 机器生成。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431626860","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431626860","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431626860?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:41","pubTimestamp":1714401664,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时41分，Emergent Biosolutions, Inc.股票出现异动，股价快速拉升5.21%。截至发稿，该股报2.02美元/股，成交量18.952万股，换手率0.36%，振幅4.68%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.59%。其相关个股中，Deciphera Pharmaceuticals, Inc.、Phibro Animal Health Corporation、Scynexis, Inc.涨幅较大，Akanda Corp.、Sunshine Biopharma Inc.、Deciphera Pharmaceuticals, Inc.较为活跃，换手率分别为279.96%、268.88%、42.03%，振幅较大的相关个股有Clever Leaves Holdings Inc C/Wts 18/12/2025、Painreform Ltd.、Akanda Corp.，振幅分别为36.81%、21.73%、17.48%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292241047a573435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292241047a573435&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286112","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286112","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286112?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:42","pubTimestamp":1714052524,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时42分，Emergent Biosolutions, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报2.07美元/股，成交量4.2042万股，换手率0.08%，振幅2.67%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体跌幅为0.23%。其相关个股中，Optinose, Inc.、Biofrontera Inc C/Wts 27/10/2026 、阿斯利康涨幅较大，Sunshine Biopharma Inc.、Optinose, Inc.、Fsd Pharma Inc.较为活跃，换手率分别为772.49%、9.03%、1.39%，振幅较大的相关个股有Optinose, Inc.、Fsd Pharma Inc.、Organogenesis Holdings Inc.，振幅分别为16.21%、15.20%、13.08%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214204861e90af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425214204861e90af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429945390","title":"BUZZ-美国食品和药物管理局（FDA）批准非处方用药过量逆转鼻腔喷雾剂，Amneal 公司业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2429945390","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429945390?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:55","pubTimestamp":1713963351,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月24日 - ** Amneal制药公司  股价盘前上涨11%，报5.99美元 ** 公司称美国食品和药物管理局已批准其非处方药盐酸纳洛酮鼻喷雾剂用于阿片类药物过量的紧急治疗** 公司称其盐酸纳洛酮鼻喷雾剂现已在美国上市 ** AMRX公司的喷雾剂是Emergent Biosolutions公司  纳洛酮鼻用喷雾剂的仿制药，后者于2023年获准在没有处方的情况下销售。 ** 截至上次收盘，AMRX年累计下跌约11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429538118","title":"Emergent Biosolutions, Inc.盘中异动 早盘股价大涨5.09%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429538118","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429538118?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:47","pubTimestamp":1713880062,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时47分，Emergent Biosolutions, Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报2.27美元/股，成交量5.7916万股，换手率0.11%，振幅6.48%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为0.47%。其相关个股中，Scynexis, Inc.、Esperion Therapeutics, Inc.、Procaps Group, S.A.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为140.31%、9.76%、4.69%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Cbdmd, Inc.、脑再生科技，振幅分别为16.94%、14.98%、13.82%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232147437a54ee17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232147437a54ee17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429197162","title":"Emergent Biosolutions, Inc.盘中异动 大幅拉升5.30%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429197162","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429197162?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:02","pubTimestamp":1713805350,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时02分，Emergent Biosolutions, Inc.股票出现波动，股价急速拉升5.30%。Emergent Biosolutions, Inc.股票所在的制药行业中，整体涨幅为1.24%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Evoke Pharma, Inc.涨幅较大，Sunshine Biopharma Inc.、苏轩堂、Akanda Corp.较为活跃，换手率分别为382.81%、42.11%、39.45%，振幅较大的相关个股有Cyclo Therapeutics Inc C/Wts 11/12/2025、Biofrontera Inc.、Fsd Pharma Inc.，振幅分别为59.26%、19.17%、17.14%。Emergent Biosolutions, Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102307a549de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102307a549de2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426257663","title":"Benchmark：重申Emergent BioSolutions(EBS.US)评级，由买入调整至买入评级, 目标价5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426257663","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426257663?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:16","pubTimestamp":1712841368,"startTime":"0","endTime":"0","summary":"Benchmark：重申Emergent BioSolutions(EBS.US)评级，由买入调整至买入评级, 目标价5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112116138b107ed9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112116138b107ed9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421986729","title":"飞行汽车“热辣滚烫”，万安科技股价真的能“支棱”起来吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2421986729","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2421986729?lang=zh_cn&edition=full","pubTime":"2024-03-22 17:55","pubTimestamp":1711101326,"startTime":"0","endTime":"0","summary":"2023年，万安科技以两位数的增长态势，领先同行。1月30日，万安科技公告，控股子公司安徽万安收到国内某知名飞行汽车公司出具的《定点开发通知书》，安徽万安被客户选定为某车型前副车架总成产品的供应商，要求安徽万安与其技术、质量部门对接，进行图纸、数据的确认并签订合同。在飞行汽车概念加持之下，万安科技股价真的能“支棱”起来吗？其中，气压制动系统和液压制动系统是万安科技的两大拳头产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/229329","is_publish_highlight":false,"gpt_icon":0},{"id":"2418301985","title":"《汇市简讯》欧元/美元技术面看涨，支撑位上移","url":"https://stock-news.laohu8.com/highlight/detail?id=2418301985","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418301985?lang=zh_cn&edition=full","pubTime":"2024-03-12 16:16","pubTimestamp":1710231397,"startTime":"0","endTime":"0","summary":"0808GMT   * 欧元/美元从2月的1.0695回升(EBS)，彰显看涨行情   * 一直在不断增厚的云区支撑上方交易，目前云区在1.0848-1.0931   * 14天动能保持良好，巩固了整体看涨行情   * 整体涨势有初步测试1月11日1.1000高点的空间   * 若升破1.1000高点，将上看12月高点1.1139   * 我们寻求在1.0935做多，目标 1.1135   * 美","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417590317","title":"BUZZ-Emergent BioSolutions 因 2024 年收入预期和第四季度业绩疲软而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2417590317","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417590317?lang=zh_cn&edition=full","pubTime":"2024-03-07 19:23","pubTimestamp":1709810632,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月7日 - ** 制药商Emergent BioSolutions  股价盘前下跌15.3%至2.76美元** 周三晚些时候，该公司预测2024年的营业额为9亿至11亿美元，低于华尔街预计的11.8亿美元--LSEG数据** 公司公布第四季度每股亏损 77 美分，而分析师平均预期为 19 美分。** EBS 公布第四季度营收为 2.766 亿美元，低于预期的 2.935 亿美元。** 截至上次收盘，股价在过去 12 个月下跌了 70.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417822726","title":"Emergent BioSolutions 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2417822726","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417822726?lang=zh_cn&edition=full","pubTime":"2024-03-07 07:57","pubTimestamp":1709769423,"startTime":"0","endTime":"0","summary":"   * Emergent BioSolutions Inc   报告，截至12月底的季度调整后每股亏损77美分，低于去年同期的每股收益-31美分。* 营收同比下降 16.4%，至 2.766 亿美元；分析师预期为 2.9353 亿美元。* Emergent BioSolutions 公司公布的本季度每股收益为亏损 95 美分。* 该公司的季度亏损额为 4950 万美元。* 本季度，Emergent BioSolutions Inc 的股价上涨了 42.1%。华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 5.50 美元。本摘要由 LSEG 于世界协调时 3 月 6 日晚上 11:56 的数据机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emergentbiosolutions.com","stockEarnings":[{"period":"1week","weight":1.026},{"period":"1month","weight":0.7212},{"period":"3month","weight":1.4012},{"period":"6month","weight":0.6074},{"period":"1year","weight":-0.5445},{"period":"ytd","weight":0.6208}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Emergent Biosolutions Inc.是一家专业制药公司，向医疗保健提供商和政府提供专门的产品寻求保护和提高生活品质，用于解决医疗需要和新出现的健康威胁。该公司是1998年5月在美国密歇根州成立的，随后在 2004年6月改为特拉华公司。公司拥有两个经营部门：生物防卫和生物科学。","yearOnYearQuotes":[{"month":1,"riseRate":0.722222,"avgChangeRate":0.041439},{"month":2,"riseRate":0.444444,"avgChangeRate":0.018478},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.017909},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.043075},{"month":5,"riseRate":0.555556,"avgChangeRate":0.053701},{"month":6,"riseRate":0.588235,"avgChangeRate":0.001177},{"month":7,"riseRate":0.588235,"avgChangeRate":0.072632},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.023732},{"month":9,"riseRate":0.294118,"avgChangeRate":-0.04254},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003652},{"month":11,"riseRate":0.588235,"avgChangeRate":-0.003104},{"month":12,"riseRate":0.611111,"avgChangeRate":0.046155}],"exchange":"NYSE","name":"Emergent Biosolutions","nameEN":"Emergent BioSolutions"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Emergent Biosolutions,EBS,Emergent Biosolutions股票,Emergent Biosolutions股票老虎,Emergent Biosolutions股票老虎国际,Emergent Biosolutions行情,Emergent Biosolutions股票行情,Emergent Biosolutions股价,Emergent Biosolutions股市,Emergent Biosolutions股票价格,Emergent Biosolutions股票交易,Emergent Biosolutions股票购买,Emergent Biosolutions股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emergent Biosolutions(EBS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Emergent Biosolutions(EBS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}